Trally Tirzepatide Review: Plan Prices and Confusing Dose Labels

Trally Meds names compounded tirzepatide in its weight-management catalog and displays one-month and three-month plans. The apparent tirzepatide amounts are $349 for one month and $942 for three months, but the surrounding dose labels repeat semaglutide-like values across product groups. A written medication-specific quote is essential.¹

The platform also publishes substantive billing and refund policies: payment follows prescription approval, recurring charges depend on the selected plan, and cancellation after a processed subscription charge does not ordinarily refund that cycle.¹² This review uses public information rather than enrollment or a test purchase.

Why the catalog is not enough for a prescription decision

The page labels both compounded semaglutide and compounded tirzepatide. It displays $249/$672 amounts and $349/$942 amounts in separate groups, with repeated dose text such as 0.25–1 mg weekly and 1.5–2.5 mg weekly.¹

Those repeated labels do not establish an accurate tirzepatide titration or quantity schedule. Do not use them as administration instructions or assume the same strengths apply to both drugs. Obtain the actual molecule, formulation, concentration, prescribed milligrams and number of doses from the clinician and pharmacy.

The catalog supports the existence of a named offer, but its presentation does not justify claiming a complete, verified dose-specific tirzepatide quote. We preserve that distinction instead of treating a potentially copied label as medical information.

One month versus three months

The three-month $942 display is a total package amount, not a $942 monthly charge. Dividing it produces an arithmetic equivalent, but still does not establish how payment, medication supply or dose changes work for the selected prescription.¹

Ask whether the plan is paid upfront or in installments, how many shipments arrive and what happens if the clinician changes treatment. Confirm care reviews, supplies and shipping. A longer-supply discount can create a larger financial commitment even when the average monthly figure is lower.

The page markets no separate membership cost. That does not mean the medication plan cannot renew automatically. A recurring medicine subscription and an additional membership fee are different charges.

Approval and automatic billing

The product page describes an initial authorization hold at checkout, with a charge after a provider issues the prescription. It says later charges follow ongoing check-in and provider approval.¹

The billing terms say most plans are subscriptions, with six- and twelve-month supply exceptions. Charges follow the chosen treatment interval until cancellation or prescription expiration.² Obtain the next charge date and whether any remaining installments are owed if treatment stops.

The billing policy allows cancellation through the portal, phone or email without an additional cancellation fee. A cancellation after a subscription charge is processed does not produce a refund for that billing cycle, while later cycles stop after confirmation.² Keep the confirmation rather than assuming a request automatically reverses an existing charge.

Shipment and refund policy raise another question

The refund page says prescription sales are final once payment is charged and the package is handed to the carrier. It describes help for damaged or lost deliveries. It also contains a broad statement that the company does not ship refrigerated products.³

That wording needs clarification for a proposed injectable GLP-1 prescription. Ask the actual pharmacy for the formulation's storage requirements, shipping controls and process for a warm shipment. FDA has raised concerns about inadequate refrigeration of injectable compounded GLP-1 medicine and recommends not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated.⁵

We do not infer from the policy alone what temperature any patient's package reached. The correct action is to resolve the actual product's handling instructions before use, not to assume a generic shipping statement validates it.

Clinical and pharmacy accountability

Trally's general terms and FAQs describe clinical services and U.S.-based, state-dependent eligibility. The reviewed information does not establish the individual clinician or dispensing pharmacy for an order.⁴ Obtain both identities and check state authorization.

Compounded tirzepatide is not the FDA-approved branded product. The name and a free-visit invitation do not independently establish product quality, equivalence or a guaranteed treatment result.⁵ Ask the clinician to discuss approved alternatives and why the proposed formulation meets the medical need.

Our assessment

Trally publishes a real named offer and useful billing terms, but the dose labels and shipping wording are material unresolved issues. Compare only a clarified written prescription and complete order, using other provider reviews, the care-options guide and Zepbound cost options.

To compare what a written prescription-specific quote must clarify before ordering, see Evergreen and Mirabel Meds.